Asthma Treatment Drugs Market Scope
Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. Symptoms include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The predisposing factors include family history, overweight, smoking, exposure to exhaust fumes or other types of pollution and exposure to occupational triggers, such as chemicals used in farming, hairdressing and manufacturing. Treatment includes inhaled corticosteroids, leukotriene modifiers, antihistamines and decongestants.
The Asthma Treatment Drugs market study is segmented by Type (Long-term Control Medications, Quick-relief Medications (Rescue Medications) and Medications for Allergy-induced Asthma), by Application (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
AstraZeneca (United Kingdom), GlaxoSmithKline (United Kingdom), Teva (Israel), Merck (United Kingdom), Boehringer Ingelheim (Germany), Sanofi (France) BEXIMCO Pharmaceuticals (Bangladesh), Cipla Inc (India), PNEUMA Respiratory (United States), H&T Presspart (United Kingdom) and Pfizer (United Kingdom) are some of the key players that are part of study coverage.
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AMA Research has segmented the market of Global Asthma Treatment Drugs market by Type, Application and Region.
On the basis of geography, the market of Asthma Treatment Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Drug maker Lupin launched Budesonide Inhalation Suspension single-dose ampules, used to treat asthma, in the US market. The company has launched its generic product after receiving the approval from the US Food and Drug Administration (USFDA), Lupin said in a statement. and On 11 August 2020 Drug firm Lupin on it has launched generic Zileuton extended-release tablets - used for the treatment of asthma - in the US market.The product is a generic version of Chiesi USA Inc's Zyflo CR extended-release tablets in the same strength, it added.
- Technological Advancements In The Development Of Asthma Drugs
- Rising Prevalence of Asthma
- Favorable Government Initiatives Fuels the Awareness of Asthma Drugs
- Introduction Of Asthma Treatment Drugs In Developing Regions
- Rise In Research & Development Costs In The Pharmaceutical Industries
- High Penetration Of Generic Drugs
- Government Strict Regulations For The Approval Of Asthma Drugs
Key Target AudienceAsthma Treatment Drugs Service Provider, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others